Section Arrow
ASND.NASDAQ
- Ascendis Pharma A/S
Quotes are at least 15-min delayed:2024/05/19 09:43 EDT
Last
 121.12
-1.68 (-1.37%)
Day High 
124.76 
Prev. Close
122.8 
1-M High
147.45 
Volume 
690.04K 
Bid
121.13
Ask
121.28
Day Low
120.02 
Open
123.06 
1-M Low
116.625 
Market Cap 
6.95B 
Currency USD 
P/E -- 
%Yield
10-SMA 131.14 
20-SMA 135.76 
50-SMA 143.04 
52-W High 161 
52-W Low 83.75 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-8.87/-0.06
Enterprise Value
7.57B
Balance Sheet
Book Value Per Share
-4.54
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
266.72M
Operating Revenue Per Share
2.84
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NBYNovaBay Pharmaceuticals0.1186-0.0014-1.17%-- 
SCPXScorpius Holdings0.1035+0.0034+3.40%-- 
JAGXJaguar Health0.2585-0.0282-9.84%-- 
DNAGinkgo Bioworks Holdings0.8056-0.0334-3.98%-- 
ONCOOnconetix0.156+0.015+10.64%-- 
Quotes are at least 15-min delayed:2024/05/19 09:43 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.